← 產業報告目錄
Gene Switch / Molecular Switch Market, Share & Trends Analysis Report, Distribution by Application Area (Management of Treatment Related Toxicity, Regulation of Gene Expression), Type of Target Therapy (CAR T Cell Therapy, Gene Therapy), Type of Payment Model Employed, By Region, and Segment Forecasts, 2024-2031
出版商 InsightAce Analytic產業別 Healthcare & Life Sciences出版日期 2026-03-28頁數 168報告編號 INSIGHTACE-872de9313d
授權報價
| Single User PDF | $4,500 USD |
| Global Site License PDF | $9,500 USD |
報告摘要
In 2023, the Gene Switch / Molecular Switch Market worldwide was assessed at USD 0.69 Bn. Analysts project it will expand to USD 1.44 Bn by 2031, at a CAGR of 9.9% spanning 2024 to 2031.
At its core, Gene Switch / Molecular Switch pertains to locations on genes that are capable of binding regulatory molecules to start the transcription and translation processes that result in the expression of that particular gene. Stakeholders across the healthcare landscape are mountingly turning to these solutions to meet contemporary demands.
Market momentum is underpinned by mounting interest in advanced solutions, favorable regulatory frameworks, and robust investment in research and development across major economies.
The market landscape is structured across several key segments—spanning type, application, distribution channel, and region—each contributing uniquely to overall market expansion.
Regional dynamics show North America and Europe as established hubs, with the Asia-Pacific region poised to deliver the strongest growth trajectory through the forecast period, underpinned by demographic shifts and policy support.
Competition in this space is characterized by active product development, strategic collaborations, and geographic expansion among both global leaders and specialized niche players.
This comprehensive research study delivers granular insights into market sizing, trend analysis, competitive benchmarking, and forward-looking projections to support strategic decision-making for industry participants and investors.
目錄 Table of Contents
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Gene Switch / Molecular Switch Market Snapshot
Chapter 4. Global Gene Switch / Molecular Switch Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis – Porter's Five Forces Analysis
4.7. Competitive Landscape & Market Share Analysis
4.8. Impact of Covid-19 Analysis
Chapter 5. Market Segmentation 1: Type of Payment Model Employed Area Estimates & Trend Analysis
5.1. Type of Payment Model Employed Area & Market Share, 2019 & 2031
5.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following Type of Payment Model Employed Area:
5.2.1. Management of Treatment Related Toxicity
5.2.2. Regulation of Gene Expression
5.2.3. Other Applications
Chapter 6. Market Segmentation 2: Type of Target Therapy Estimates & Trend Analysis
6.1. Type of Target Therapy & Market Share, 2019 & 2031
6.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following Type of Target Therapy:
6.2.1. CAR T Cell Therapy
6.2.2. Gene Therapy
6.2.3. Other Therapies
Chapter 7. Market Segmentation 3: Type of Payment Model Employed Estimates & Trend Analysis
7.1. Type of Payment Model Employed & Market Share, 2019 & 2031
7.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following Type of Payment Model Employed:
7.2.1. Upfront Payments
7.2.2. Milestone Payments
Chapter 8. Gene Switch / Molecular Switch Market Segmentation 4: Regional Estimates & Trend Analysis
8.1. North America
8.1.1. North America Gene Switch / Molecular Switch Market Revenue (US$ Million) Estimates and Forecasts Type of Payment Model Employed Area, 2024-2031
8.1.2. North America Gene Switch / Molecular Switch Market Revenue (US$ Million) Estimates and Forecasts Type of Target Therapy, 2024-2031
8.1.3. North America Gene Switch / Molecular Switch Market Revenue (US$ Million) Estimates and Forecasts Type of Payment Model Employed, 2024-2031
8.1.4. North America Gene Switch / Molecular Switch Market Revenue (US$ Million) Estimates and Forecasts by country, 2024-2031
8.2. Europe
8.2.1. Europe Gene Switch / Molecular Switch Market Revenue (US$ Million) Estimates and Forecasts Type of Payment Model Employed Area, 2024-2031
8.2.2. Europe Gene Switch / Molecular Switch Market Revenue (US$ Million) Estimates and Forecasts Type of Target Therapy, 2024-2031
8.2.3. Europe Gene Switch / Molecular Switch Market Revenue (US$ Million) Estimates and Forecasts Type of Payment Model Employed, 2024-2031
8.2.4. Europe Gene Switch / Molecular Switch Market Revenue (US$ Million) Estimates and Forecasts by country, 2024-2031
8.3. Asia Pacific
8.3.1. Asia Pacific Gene Switch / Molecular Switch Market Revenue (US$ Million) Estimates and Forecasts Type of Payment Model Employed Area, 2024-2031
8.3.2. Asia Pacific Gene Switch / Molecular Switch Market Revenue (US$ Million) Estimates and Forecasts Type of Target Therapy, 2024-2031
8.3.3. Asia-Pacific Gene Switch / Molecular Switch Market Revenue (US$ Million) Estimates and Forecasts Type of Payment Model Employed, 2024-2031
8.3.4. Asia Pacific Gene Switch / Molecular Switch Market Revenue (US$ Million) Estimates and Forecasts by country, 2024-2031
8.4. Latin America
8.4.1. Latin America Gene Switch / Molecular Switch Market Revenue (US$ Million) Estimates and Forecasts Type of Payment Model Employed Area, 2024-2031
8.4.2. Latin America Gene Switch / Molecular Switch Market Revenue (US$ Million) Estimates and Forecasts Type of Target Therapy, 2024-2031
8.4.3. Latin America Gene Switch / Molecular Switch Market Revenue (US$ Million) Estimates and Forecasts Type of Payment Model Employed, 2024-2031
8.4.4. Latin America Gene Switch / Molecular Switch Market Revenue (US$ Million) Estimates and Forecasts by country, 2024-2031
8.5. Middle East & Africa
8.5.1. Middle East & Africa Gene Switch / Molecular Switch Market Revenue (US$ Million) Estimates and Forecasts Type of Payment Model Employed Area, 2024-2031
8.5.2. Middle East & Africa Gene Switch / Molecular Switch Market Revenue (US$ Million) Estimates and Forecasts Type of Target Therapy, 2024-2031
8.5.3. Middle East & Africa Gene Switch / Molecular Switch Market Revenue (US$ Million) Estimates and Forecasts Type of Payment Model Employed, 2024-2031
8.5.4. Middle East & Africa Gene Switch / Molecular Switch Market Revenue (US$ Million) Estimates and Forecasts by country, 2024-2031
Chapter 9. Competitive Landscape
9.1. Major Mergers and Acquisitions/Strategic Alliances
9.2. Company Profiles
9.2.1. aceRNA Technologies
9.2.2. Autolus Therapeutics
9.2.3. Bellicum Pharmaceuticals
9.2.4. Cellectis
9.2.5. Kiromic BioPharma
9.2.6. panCELLa
9.2.7. Precigen,
9.2.8. Sana Biotechnology
9.2.9. Sangamo Therapeutics
9.2.10. Editas Medicine
9.2.11. Other Prominent Players
量子訊息有限公司為 InsightAce Analytic 在台灣的授權代理,提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們